Absence of evidence of Borna disease virus infection in Swedish patients with Chronic Fatigue Syndrome

References

• Bennet A L, Chao C C, Hu S, Buchwald D, Fagioli L R, Schur P H, Peterspm P K, Komaroff A L. Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome. J Clin Immunol 1997; 17: 160–166
   Google Scholar
• Bode L, Komaroff A L, Ludwig H. No serologic evidence of Borna disease virus in patients with chronic fatigue syndrome. Clin Infect Dis 1992; 15: 1049
   Google Scholar
• Bode L, Zimmermann W, Ferszt R, Steinbach F, Ludwig H. Borna disease virus genome transcribed and expressed in psychiatric patients. Nature Med 1995; 1: 232–236
   PubMed Web of Science ®Google Scholar
• Briese T, Schneemann A, Lewis A J, Park Y-S, Kim S, Ludwig H, Lipkin W L. Genomic organization of Borna disease virus. Proc Natl Acad Sci USA 1994; 91: 4362–4366
   PubMed Web of Science ®Google Scholar
• Briese T, Hatalski C G, Kliche S, Park Y, Lipkin W I. Enzyme-linked immunosorbent assay for detecting antibodies to Borna Disease virus-specific proteins. J Clin Microbiol 1995; 33: 348–351
   PubMed Web of Science ®Google Scholar
• Buchwald D, Ashley R L, Pearlman T, Kith P, Komaroff A L. Viral serologies in patients with Chronic fatigue and Chronic fatigue syndrome. J Med Virol 1996; 50: 25–30
   PubMed Web of Science ®Google Scholar
• Cannon J G, Angel J B, Abad L W, Vannier E, Mileno M D, Fagioli L, Wolff S M, Komaroff A L. Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. J Clin Immunol 1997; 17: 253–261
   PubMed Web of Science ®Google Scholar
• Fukuda K, Straus S E, Hickie I, Sharpe M C, Dobbins J G, Komaroff A L. The Chronic fatigue syndrome. A comprehensive approach to its definition and study. International chronic fatigue syndrome case definition study group. Ann Int Med 1994; 121: 953–959
   PubMed Web of Science ®Google Scholar
• Gupta S, Aggarwal S, See D, Starr A. Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. J Psychiatr Res 1997; 31: 149–156
   PubMed Web of Science ®Google Scholar
• Hatalski C G, Lewis A L, Lipkin W I. Borna disease virus epidemiology and pathogenesis. Emerging Inf Dis 1997; 3: 129–135
   Google Scholar
• Jones J F, Ray C G, Minnich L L, Hicks M J, Kibler R, Lucas D O. Evidence of active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: Elevated anti-early antigen antibodies. Ann Intern Med 1985; 102: 1–7
   PubMed Web of Science ®Google Scholar
• Kishi M, Nakaya T, Nakamura Y, Zhong Q, Ikeda K, Senjo M, Kakinuma M, Kato S, Ikuta K. Demonstration of human Borna disease virus RNA in human peripheral blood mononuclear cells. FEBS Lett 1995; 364: 293–297
   Google Scholar
• Kitani T, Kuratsune H, Fuke I, Nakamura Y, Nakaya T, Asahi S, Tobiume M, Yamaguti K, Macchii T, Inagi R, Yamanishi K, Ikuta K. Possible correlation between Borna disease virus infection and Japanese patients with Chronic fatigue syndrome. Microbiol Immunol 1996; 40: 459–462
   PubMed Web of Science ®Google Scholar
• Kliche S, Stitz L, Mangalam H, Shi L, Binz T, Niemann H, Briese T, Lipkin W I. Characterization of the Borna disease virus phosphoprotein, p23. J Virol 1996; 70: 8133–8137
   Google Scholar
• Landay A L, Jessop C, Lennette E T, Levy J A. Chronic fatigue syndrome: Clinical condition associated with immune activation. Lancet 1991; 338: 707–712
   PubMed Web of Science ®Google Scholar
• Lundgren A-L, Czech G, Bode L, Ludwig H. Natural Borna disease in domestic animals other than horses and sheep. J Vet Med 1993; 40: 298–303
   Google Scholar
• Nakaya T, Takahashi H, Nakamura Y, Asahi S, Tobiume M, Kuratsune H, Kitani T, Yamanishi K, Ikuta K. Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells derived from Japanese patients with Chronic fatigue syndrome. FEBS Letters 1996; 378: 145–149
   PubMed Web of Science ®Google Scholar
• Salvatore M, Morzunov S, Schwemmle M, Lipkin W I, The Bornavirus Study Group. Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder. Lancet 1997; 349: 1813–1814
   PubMedGoogle Scholar
• Sauder C, Mueller A, Cubitt B, Mayer J, Steinmetz J, Trabert W, Ziegler B, Wanke K, Mueller-Lantzsch N, de la Torre J C, Graesser F. Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derivd BDV RNA. J Virol 1996; 70: 7713–7724
   PubMed Web of Science ®Google Scholar
• Sauder C, de Ie Torre J C. Sensitivity and reproducibility of RT—PCR to detect Borna disease virus (BDV) RNA in blood: implications for BDV epidemiology. J Virol Meth 1998; 71: 229–245
   Google Scholar
• Shimizu H, Shimizu C, Burns J C. Detection of novel RNA viruses: morbilliviruses as a model system. Molecular Cellular Probes 1994; 8: 209–214
   Google Scholar
• Straus S E, Tosato G, Armstrong G, Lawley T, Preble O, Henle W, Davey R, Pearson G, Epstein J, Brus I, Blese R M. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 1985; 102: 7–16
   PubMed Web of Science ®Google Scholar